drugset / Trial / NCT03307863

Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy

NCT03307863 ↗

Phase 4 Suspended 69 enrolled University of Sao Paulo
Non-randomizedParallel-groupSingle-blindOther

Summary

Data on the interaction between the etonogestrel (ENG) implant and antiepileptic drug (AED) regimen are scarce. We will evaluated the effect of 2 AED regimens (1 including carbamazepine and the other topiramate) on the pharmacokinetic (PK) parameters of an ENG-releasing implant in women with epilepsy.

Timeline

Start
2017-11-01
Primary completion
2027-11-30
Completion
2028-11-30

Outcome

Outcome not reported

Stopped: “We suspended the study for budget issues. It might be resumed in the future.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbamazepine Small molecule — —
Comparator Etonogestrel Unknown — —
Subject Topiramate Small molecule — —

Indications

No indication recorded.